Client Reviews
Not yet reviewed
No professional misconduct found.
Overview
Practice Areas
|
-
50% Life Sciences / Biotechnology
-
50% Federal Regulation
|
Contact Information
|
|
References
Client Reviews
|
How would you rate this lawyer?
If you're a current or former client, share your thoughts (anonymously, if you prefer). Would you recommend this lawyer to other clients?
Review this lawyer
|
Peer Endorsements
|
Endorse a fellow lawyer, get more visits to your profile
In addition to providing a simple way to express your gratitude to fellow lawyers, any time you add an endorsement to a peer's profile, a link to your profile will appear on it.
Endorse this lawyer
|
Résumé
License
|
13 years since Jodi Finder was first licensed to practice law.
| State |
License status |
Year acquired |
Last updated by Avvo |
| Maryland |
Active
|
1998 |
11/01/2007 |
| New York |
Currently registered
|
2006 |
05/21/2011 |
We have not found any instances of professional misconduct for this lawyer.
|
Education
|
| School |
Major |
Degree |
Graduated |
| George Washington University National Law Center |
Law |
JD - Juris Doctor |
1998 |
| Duke University |
|
BA - Bachelor of Arts |
1995 |
| George Washington University National Law Center |
|
LL.M - Master of Laws |
|
See all 3 degrees
|
Portfolio
Publications
|
| Article |
Publication |
Date |
| Practice Guidelines as the Standard of Care? |
Licensure & Discipline |
2002 |
| The Future of Practice Guidelines: Should They Constitute Conclusive Evidence of the Standard of Care? |
Health Matrix |
2000 |
| General Permits Under Wetlands Law: The Rise & Fall of Nationwide Permit 26 |
Environmental Law |
1997 |
See all 3 publications
|
Speaking Engagements
|
| Presentation Name |
Conference |
Date |
| Understanding FDA's Regulation of Combination Drugs |
Pharmaceutical Education Associates |
2005 |
| Understanding FDA's Regulation of Fixed-Dose Combination Drugs |
Education Services |
2005 |
| FDA Enforcement Basics: 483 to Consent Decree |
Regulatory Affairs Professional Society Annual Conference |
2004 |
| Understanding FDA's Regulation of Combination Drugs |
Center for Business Intelligence |
2004 |
| Understanding FDA's Regulation of Combination Drugs |
Barnett International Conference Group |
2004 |
| Managing Clinical Research in the Post-HIPAA World: The privacy rule will permanently alter the dynamics of relationships among sponsors, investigator, IRBs, and human subjects |
MX - Business Strategies for Medical Technology Executives |
2003 |
| Association of Clinical Research Professionals |
Fraud & Noncompliance |
2003 |
| Managing the Oversight of Phase IV Clinical Trials: What Is the IRB's Responsibility? |
Barnett International Conference Group |
2003 |
| Legal & Regulatory Insights on Privacy Protection and HIPAA Compliance in Phase IV Clinical Trials |
Center for Business Intelligence |
2002 |
See all 9 speaking engagements
|
|
